P. Hammerness

发表

Pediatric ADHD and the Cultural Psychotherapeutic Model July 31

Martin J. La Roche, Olivia Carrick, P. Hammerness, 2017 .

Pediatric ADHD and the cultural psychotherapeutic model

Olivia Carrick, P. Hammerness, 2015 .

Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate.

S. Faraone, J. Biederman, T. Spencer, 2013, The Journal of pediatrics.

The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm.

Kathryn M. Godfrey, B. Reimer, Bruce Mehler, 2012, Journal of psychiatric research.

The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire.

Kathryn M. Godfrey, B. Reimer, Bruce Mehler, 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Reliability and Validity of the Before-School Functioning Scale in Children With ADHD

S. Faraone, T. Wilens, P. Hammerness, 2018, Journal of attention disorders.

Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes

G. Bush, M. Monuteaux, N. Makris, 2007, Psychological Medicine.

An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics.

J. Biederman, T. Wilens, P. Hammerness, 2009, Journal of child and adolescent psychopharmacology.

Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.

D. Geller, P. Hammerness, F. Vivas, 2006, The Journal of pediatrics.

Cardiovascular Considerations for Stimulant Class Medications.

T. Wilens, P. Hammerness, A. Berger, 2022, Child and adolescent psychiatric clinics of North America.

Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration

E. Basch, H. Boon, C. Ulbricht, 2005, Expert opinion on drug safety.

Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration.

E. Basch, C. Ulbricht, E. Rusie-Seamon, 2009, Journal of the Society for Integrative Oncology.

A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulation.

J. Biederman, S. Lukas, C. Moore, 2012, The Israel journal of psychiatry and related sciences.

Reexamining the Familial Association Between Asthma and ADHD in Girls

M. Monuteaux, S. Faraone, J. Biederman, 2005, Journal of attention disorders.

Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study

J. Biederman, P. Hammerness, G. Joshi, 2009, European Child & Adolescent Psychiatry.

An Evidence-Based Systematic Review of Elderberry and Elderflower (Sambucus nigra) by the Natural Standard Research Collaboration

E. Basch, C. Ulbricht, W. Weissner, 2014, Journal of dietary supplements.

A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder.

S. Faraone, J. Biederman, P. Hammerness, 2010, Journal of affective disorders.

A Randomized, Single-Blind, Substitution Study of OROS Methylphenidate (Concerta) in ADHD Adults Receiving Immediate Release Methylphenidate

J. Biederman, E. Mick, T. Spencer, 2011, Journal of attention disorders.

Fenugreek (Trigonella foenum-graecum L. Leguminosae): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration

E. Basch, C. Ulbricht, W. Weissner, 2008, Journal of herbal pharmacotherapy.

St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist.

E. Basch, H. Boon, C. Ulbricht, 2003, Psychosomatics.

A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents.

S. Sprich, S. Safren, P. Hammerness, 2016, Journal of child psychology and psychiatry, and allied disciplines.

An Evidence-Based Systematic Review of Gymnema (Gymnema sylvestre R. Br.) by the Natural Standard Research Collaboration

E. Basch, C. Ulbricht, W. Weissner, 2011, Journal of dietary supplements.

An Open-Label Trial of OROS Methylphenidate in Adults with Late-Onset ADHD

J. Biederman, E. Mick, T. Spencer, 2006, CNS Spectrums.

Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?

P. Hammerness, M. Alexander, R. Babalola, 2015, Expert opinion on drug safety.

Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration.

E. Basch, H. Boon, C. Ulbricht, 2006, Journal of the Society for Integrative Oncology.

Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.

L. Garraway, E. Basch, H. Boon, 2005, Complementary therapies in medicine.

Wild yam (Dioscoreaceae).

E. Basch, C. Ulbricht, P. Hammerness, 2003, Journal of herbal pharmacotherapy.

Atomoxetine in the Treatment of Adults with Subthreshold and/or Late Onset Attention‐Deficit Hyperactivity Disorder‐Not Otherwise Specified (ADHD‐NOS): A Prospective Open‐Label 6‐Week Study

J. Biederman, P. Hammerness, R. Doyle, 2010, CNS neuroscience & therapeutics.

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.

J. Biederman, T. Spencer, T. Wilens, 2005, The Journal of clinical psychiatry.

Do Stimulants Reduce the Risk for Alcohol and Substance Use in Youth With ADHD? A Secondary Analysis of a Prospective, 24-Month Open-Label Study of Osmotic-Release Methylphenidate

S. Faraone, J. Biederman, P. Hammerness, 2017, Journal of attention disorders.

An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.

T. Wilens, P. Hammerness, R. Doyle, 2009, Journal of child and adolescent psychopharmacology.

New stimulant formulations for pediatric attention-deficit/hyperactivity disorder: a case-based approach for the primary care provider

P. Hammerness, Paige I Partain, Jacob White, 2019, Current opinion in pediatrics.

Shark cartilage monograph: a clinical decision support tool.

E. Basch, H. Boon, C. Ulbricht, 2002, Journal of herbal pharmacotherapy.

Hops (Humulus lupulus): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration

E. Basch, C. Ulbricht, W. Chao, 2012 .

Examining the Nature of the Association between Attention-Deficit Hyperactivity Disorder and Nicotine Dependence: A Familial Risk Analysis

S. Faraone, J. Biederman, K. Woodworth, 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

An Evidence-Based Systematic Review of Aloe vera by the Natural Standard Research Collaboration

E. Basch, C. Ulbricht, W. Weissner, 2008, Journal of herbal pharmacotherapy.

Thyme (Thymus vulgaris L.), thymol.

E. Basch, C. Ulbricht, P. Hammerness, 2004, Journal of herbal pharmacotherapy.

An Evidence-Based Systematic Review of Blessed Thistle (Cnicus benedictus) by the Natural Standard Research Collaboration

E. Basch, C. Ulbricht, W. Weissner, 2008 .

An Evidence-Based Systematic Review of Vitamin A by the Natural Standard Research Collaboration

E. Basch, W. Chao, D. Costa, 2012, Journal of dietary supplements.

Genitourinary and Sexual Adverse Effects of Psychotropic Medication

M. Pollack, P. Hammerness, S. Reiter, 1992, International journal of psychiatry in medicine.

Open-Label, 8-Week Trial of Olanzapine and Risperidone for the Treatment of Bipolar Disorder in Preschool-Age Children

J. Biederman, E. Mick, M. Aleardi, 2005, Biological Psychiatry.

An Evidence-Based Systematic Review of Belladonna by the Natural Standard Research Collaboration

E. Basch, C. Ulbricht, J. Woods, 2004, Journal of herbal pharmacotherapy.

Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration.

E. Basch, C. Ulbricht, W. Weissner, 2007, Journal of the Society for Integrative Oncology.

A Case of Emotional Trauma in the Setting of Neurodevelopmental Disability.

D. Acar, P. Hammerness, Jason M. Fogler, 2018, Harvard review of psychiatry.

Diagnostic utility of brain activity flow patterns analysis in attention deficit hyperactivity disorder

S. Faraone, A. Geva, J. Biederman, 2017, Psychological Medicine.

An Open-Label Trial of Aripiprazole Monotherapy in Children and Adolescents with Bipolar Disorder

J. Biederman, E. Mick, T. Spencer, 2007, CNS Spectrums.

Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

P. Renshaw, J. Biederman, E. Mick, 2007, Journal of affective disorders.

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder

J. Biederman, T. Spencer, T. Wilens, 2003, Biological Psychiatry.

Is Oppositional Defiant Disorder a Meaningful Diagnosis in Adults?: Results From a Large Sample of Adults With ADHD

J. Biederman, E. Mick, Anya I Potter, 2007, The Journal of nervous and mental disease.

The influence of DST and TRH test administration on depression assessments: A controlled study

M. Fava, J. Rosenbaum, B. Lafer, 1993, Biological Psychiatry.

Essiac: systematic review by the natural standard research collaboration.

C. Ulbricht, W. Weissner, P. Hammerness, 2009, Journal of the Society for Integrative Oncology.

Do stimulants improve functioning in adults with ADHD? A review of the literature

S. Faraone, P. Hammerness, C. Surman, 2013, European Neuropsychopharmacology.

Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study.

P. Renshaw, J. Biederman, E. Mick, 2006, The American journal of psychiatry.

Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.

P. Hammerness, E. Chan, Jason M. Fogler, 2016, JAMA.

Stimulant Pharmacotherapy for Adults with ADHD

P. Hammerness, 2013 .

Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications

P. Hammerness, C. Surman, Ashley Chilton, 2011, Current psychiatry reports.

A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

J. Biederman, E. Mick, T. Spencer, 2010, Journal of clinical psychopharmacology.

A Prospective Open‐Label Trial of Lamotrigine Monotherapy in Children and Adolescents with Bipolar Disorder

J. Biederman, E. Mick, P. Hammerness, 2010, CNS neuroscience & therapeutics.

A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.

J. Biederman, E. Mick, M. Aleardi, 2010, Journal of child and adolescent psychopharmacology.

Cigarette smoking as a risk factor for other substance misuse: 10-year study of individuals with and without attention-deficit hyperactivity disorder

S. Faraone, J. Biederman, P. Hammerness, 2012, British Journal of Psychiatry.

Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.

T. Wilens, P. Hammerness, J. Perrin, 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their families.

M. Monuteaux, S. Faraone, J. Biederman, 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.

J. Biederman, E. Mick, T. Spencer, 2009, The Journal of pediatrics.

Assessment and Treatment of a Young Adult with Congenital Heart Disease and ADHD.

M. Augustyn, P. Hammerness, Jason M. Fogler, 2021, Journal of developmental and behavioral pediatrics : JDBP.

Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment.

J. Rigas, W. Nugent, P. Hammerness, 1997, The Annals of thoracic surgery.

A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

J. Biederman, E. Mick, T. Spencer, 2006, Biological Psychiatry.

Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents.

S. Faraone, T. Spencer, L. Adler, 2012, Journal of child and adolescent psychopharmacology.

Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD

J. Biederman, R. Fried, P. Hammerness, 2014, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

J. Biederman, E. Mick, T. Spencer, 2007, BMC psychiatry.

Risperidone treatment for ADHD in children and adolescents with bipolar disorder

J. Biederman, E. Mick, M. Aleardi, 2008, Neuropsychiatric disease and treatment.

Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate

S. Faraone, T. Wilens, N. Desousa, 2021, Journal of attention disorders.

A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.

T. Wilens, P. Hammerness, Linsey M. Utzinger, 2010, The Journal of clinical psychiatry.

A 2009 update on adult ADHD

P. Hammerness, C. Surman, Katherine Miller, 2009 .

Update on adult attention-deficit/hyperactivity disorder

P. Hammerness, C. Surman, Katherine Miller, 2008, Current neurology and neuroscience reports.

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review

D. Geller, P. Hammerness, Katherine D McCarthy, 2009, Neuropsychiatric disease and treatment.

Cognitive behavior therapy for treatment-refractory panic disorder.

J. Rosenbaum, M. Pollack, M. Otto, 1994, The Journal of clinical psychiatry.

A controlled study of a simulated workplace laboratory for adults with attention deficit hyperactivity disorder

S. Faraone, J. Biederman, R. Fried, 2012, Psychiatry Research.

An open-label trial of divalproex sodium extended release for pediatric bipolar spectrum disorder in children age 6 - 12 years *

J. Biederman, K. Woodworth, P. Hammerness, 2012 .

Characterizing non-OCD anxiety disorders in psychiatrically referred children and adolescents.

Joseph Biederman, J. Biederman, P. Hammerness, 2008, Journal of affective disorders.

Impact of Long-Term Treatment with OROS Methylphenidate on Pubertal Development in Adolescents with ADHD

J. Biederman, T. Spencer, D. Geller, 2014 .

A pilot open label prospective study of memantine monotherapy in adults with ADHD

J. Biederman, T. Spencer, P. Hammerness, 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Linezolid: MAOI activity and potential drug interactions.

P. Hammerness, Annah Abrams, H. Parada, 2002, Psychosomatics.

A Double-blind Comparison of Galantamine Hydrogen Bromide and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder: A Pilot Study

S. Faraone, J. Biederman, E. Mick, 2006, Journal of clinical psychopharmacology.

Chaparral Monograph

E. Basch, C. Ulbricht, P. Hammerness, 2003, Journal of herbal pharmacotherapy.

Response to Second Generation Antipsychotics in Youth with Comorbid Bipolar Disorder and Autism Spectrum Disorder

J. Biederman, E. Mick, K. Woodworth, 2012, CNS neuroscience & therapeutics.

A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder

T. Wilens, A. Baggish, P. Hammerness, 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Thyme (Thymus vulgaris L.), Thymol

E. Basch, C. Ulbricht, P. Hammerness, 2004, Journal of herbal pharmacotherapy.

Does ADHD moderate the manifestation of anxiety disorders in children?

J. Biederman, D. Geller, P. Hammerness, 2010, European Child & Adolescent Psychiatry.

Brain Biochemical Effects of Methylphenidate Treatment Using Proton Magnetic Spectroscopy in Youth with Attention‐Deficit Hyperactivity Disorder: A Controlled Pilot Study

J. Biederman, C. Moore, P. Hammerness, 2012, CNS neuroscience & therapeutics.

Atomoxetine for the treatment of attention-de ﬁ cit/ hyperactivity disorder in children and adolescents: a review

D. Geller, P. Hammerness, Katherine D McCarthy, 2009 .

Adjunctive yohimbine for treatment in refractory depression

M. Pollack, P. Hammerness, 1993, Biological Psychiatry.